Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structural and Mechanistic Basis for the Inactivation of Human Ornithine Aminotransferase by (3S,4S)-3-Amino-4-fluorocyclopentenecarboxylic Acid

Journal Article · · Molecules

Ornithine aminotransferase (OAT) is overexpressed in hepatocellular carcinoma (HCC), and we previously showed that inactivation of OAT inhibits the growth of HCC. Recently, we found that (3S,4S)-3-amino-4-fluorocyclopentenecarboxylic acid (5) was a potent inactivator of γ-aminobutyric acid aminotransferase (GABA-AT), proceeding by an enamine mechanism. Here we describe our investigations into the activity and mechanism of 5 as an inactivator of human OAT. We have found that 5 exhibits 10-fold less inactivation efficiency (kinact/KI) against hOAT than GABA-AT. A comprehensive mechanistic study was carried out to understand its inactivation mechanism with hOAT. pKa and electrostatic potential calculations were performed to further support the notion that the α,β-unsaturated alkene of 5 is critical for enhancing acidity and nucleophilicity of the corresponding intermediates and ultimately responsible for the improved inactivation efficiency of 5 over the corresponding saturated analogue (4). Intact protein mass spectrometry and the crystal structure complex with hOAT provide evidence to conclude that 5 mainly inactivates hOAT through noncovalent interactions, and that, unlike with GABA-AT, covalent binding with hOAT is a minor component of the total inhibition which is unique relative to other monofluoro-substituted derivatives. Furthermore, based on the results of transient-state measurements and free energy calculations, it is suggested that the α,β-unsaturated carboxylate group of PLP-bound 5 may be directly involved in the inactivation cascade by forming an enolate intermediate. Overall, compound 5 exhibits unusual structural conversions which are catalyzed by specific residues within hOAT, ultimately leading to an enamine mechanism-based inactivation of hOAT through noncovalent interactions and covalent modification.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
2423630
Journal Information:
Molecules, Journal Name: Molecules Journal Issue: 3 Vol. 28; ISSN 1420-3049
Publisher:
MDPICopyright Statement
Country of Publication:
United States
Language:
English

References (44)

UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
Ornithine aminotransferase promoted the proliferation and metastasis of non‐small cell lung cancer via upregulation of miR‐21 journal December 2018
Ornithine Aminotransferase versus GABA Aminotransferase: Implications for the Design of New Anticancer Drugs: ORNITHINE AMINOTRANSFERASE VS. GABA AMINOTRANSFERASE journal August 2014
Theoretical calculation of the pKa values of some drugs in aqueous solution journal August 2011
The Multiple Active Enzyme Species of γ-Aminobutyric Acid Aminotransferase Are Not Isozymes journal February 2000
Crystal structure of human recombinant ornithine aminotransferase journal March 1998
Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine 1 1 1Edited by R. Huber journal January 1999
Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters journal November 2012
Mechanism of inactivation of γ-aminobutyric acid aminotransferase by ( S,E )-4-amino-5-fluoropent-2-enoic acid journal February 1988
[10] Mechanism-based enzyme inactivators book January 1995
Highly selective directed hydrogenation of enantiopure 4-( tert -butoxycarbonylamino)cyclopent-1-enecarboxylic acid methyl esters journal February 2001
Structure, evolution and action of vitamin B6-dependent enzymes journal December 1998
Two continuous coupled assays for ornithine-δ-aminotransferase journal September 2013
Syntheses and evaluation of fluorinated conformationally restricted analogues of GABA as potential inhibitors of GABA aminotransferase journal April 2006
Synthesis of neplanocin F analogues as potential antiviral agents journal December 2006
Revisit of aminotransferase in the genomic era and its application to biocatalysis journal December 2005
Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5′-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover journal September 2017
Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions journal February 2018
Synthesis of ( S )-3-Amino-4-(difluoromethylenyl)-cyclopent-1-ene-1-carboxylic Acid (OV329), a Potent Inactivator of γ-Aminobutyric Acid Aminotransferase journal July 2018
Theoretical and Mechanistic Validation of Global Kinetic Parameters of the Inactivation of GABA Aminotransferase by OV329 and CPP-115 journal March 2021
Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase journal June 2015
Mechanism-Based Design of 3-Amino-4-Halocyclopentenecarboxylic Acids as Inactivators of GABA Aminotransferase journal February 2020
Mechanism of inactivation of .gamma.-aminobutyrate aminotransferase by 4-amino-5-fluoropentanoic acid. First example of an enamine mechanism for a .gamma.-amino acid with a partition ratio of 0 journal November 1986
Mechanism of inactivation of .gamma.-aminobutyric acid-.alpha.-ketoglutaric acid aminotransferase by 4-amino-5-halopentanoic acids journal March 1981
Mechanistic Crystallography. Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1 R ,3 S ,4 S )-3-Amino-4-fluorocyclopentane-1-carboxylic Acid As Elucidated by Crystallography journal November 2004
Mechanisms of inactivation of .gamma.-aminobutyric acid aminotransferase by the antiepilepsy drug .gamma.-vinyl GABA (vigabatrin) journal November 1991
Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1 S ,3 S )-3-Amino-4-difluoromethylene-1-cyclopentanoic Acid (CPP-115) journal February 2015
Mechanisms of Inactivation of γ-Aminobutyric Acid Aminotransferase by 4-Amino-5-fluoro-5-hexenoic Acid journal January 1996
A Remarkable Difference That One Fluorine Atom Confers on the Mechanisms of Inactivation of Human Ornithine Aminotransferase by Two Cyclohexene Analogues of γ-Aminobutyric Acid journal March 2020
Turnover and Inactivation Mechanisms for ( S )-3-Amino-4,4-difluorocyclopent-1-enecarboxylic Acid, a Selective Mechanism-Based Inactivator of Human Ornithine Aminotransferase journal June 2021
Rational Design, Synthesis, and Mechanism of (3S,4R)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA Aminotransferase journal March 2022
Design and Mechanism of ( S )-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction journal January 2018
Mechanism of Inactivation of Ornithine Aminotransferase by (1 S ,3 S )-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid journal June 2019
A New Class of Conformationally Rigid Analogues of 4-Amino-5-halopentanoic Acids, Potent Inactivators of γ-Aminobutyric Acid Aminotransferase journal February 2000
Synthesis of (E)-4-amino-2,5-hexadienoic acid and (E)-4-amino-5-fluoro-2-pentenoic acid. Irreversible inhibitors of 4-aminobutyrate-2-oxoglutarate aminotransferase journal July 1986
dl-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase journal June 1990
Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1 journal April 2017
Vigabatrin: Lessons Learned From the United States Experience journal December 2018
Phaser crystallographic software journal July 2007
Features and development of Coot journal March 2010
Data processing and analysis with the autoPROC toolbox journal March 2011
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix journal October 2019
The GABA Shunt: An Attractive and Potential Therapeutic Target in the Treatment of Epileptic Disorders journal April 2005
Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug Discovery journal December 2008

Similar Records

Mechanism of Inactivation of Ornithine Aminotransferase by (1S,3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid
Journal Article · Fri Jun 28 00:00:00 EDT 2019 · Journal of the American Chemical Society · OSTI ID:1557298

Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5'-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover
Journal Article · Wed Sep 06 00:00:00 EDT 2017 · Biochemistry · OSTI ID:1438910

Inactivation of. gamma. -aminobutyric acid aminotransferase by (Z)-4-amino-2-fluorobut-2-enoic acid
Journal Article · Tue May 03 00:00:00 EDT 1988 · Biochemistry; (United States) · OSTI ID:7253565